Bergapten alleviates Parkinson's disease-like behaviors in mice by inhibiting astrocyte inflammatory activation and endoplasmic reticulum stress through the regulation of the LCN2/JAK2/STAT3 pathway
Background: Parkinson's disease (PD) is a common neurodegenerative disorder involving multiple pathological processes. Bergapten (BeG) exhibits various pharmacological activities, including anti-inflammatory, antioxidant, and neuroprotective effects, but its mechanism of action in PD remains unclear...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
University of Karachi
2026-01-01
|
| סדרה: | Pakistan Journal of Pharmaceutical Sciences |
| גישה מקוונת: | https://pjps.pk/single-article?id=cmr82c0nv00015ca34645fira |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|